Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
TSE:4883
Price:
66 JPY
-5.71%
Updated:
May 16, 2024
Modalis Therapeutics Corp
Research & Development
|
Modalis Therapeutics Corp
Research & Development Peer Comparison
Comparables:
2160
4587
4974
2929
S
4599
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Modalis Therapeutics Corp
TSE:4883
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Research & Development
-¥2.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Research & Development
-¥3.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Research & Development
-¥8.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Research & Development
-¥909m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-17%
|
|
S
|
StemRIM Inc
TSE:4599
|
Research & Development
-¥1.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Research & Development?
Research & Development
-2.1B
JPY
-2.1B
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Research & Development amounts to -2.1B JPY.
What is Modalis Therapeutics Corp's Research & Development growth rate?
Research & Development CAGR 5Y
-57%
-57%
Over the last year, the Research & Development growth was -13%. The average annual Research & Development growth rates for Modalis Therapeutics Corp have been -58% over the past three years , -57% over the past five years .
You don't have any saved screeners yet
